Target Group, Inc. (Canada) (CBDY)
0.0010
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Target Group Shareholders Equity (Quarterly) : -8.655M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.655M |
| March 31, 2026 | -8.544M |
| December 31, 2025 | -8.063M |
| September 30, 2025 | -7.434M |
| June 30, 2025 | -7.030M |
| March 31, 2025 | -6.619M |
| December 31, 2024 | -6.508M |
| September 30, 2024 | -6.997M |
| June 30, 2024 | -6.397M |
| March 31, 2024 | -7.073M |
| December 31, 2023 | -6.973M |
| September 30, 2023 | -6.855M |
| June 30, 2023 | -6.567M |
| March 31, 2023 | -7.308M |
| December 31, 2022 | -6.560M |
| September 30, 2022 | -2.783M |
| June 30, 2022 | -2.481M |
| March 31, 2022 | -2.702M |
| December 31, 2021 | -2.152M |
| September 30, 2021 | -2.105M |
| June 30, 2021 | -4.214M |
| March 31, 2021 | -5.267M |
| December 31, 2020 | -3.521M |
| September 30, 2020 | 1.727M |
| June 30, 2020 | 5.204M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.815M |
| December 31, 2019 | 10.16M |
| September 30, 2019 | 14.63M |
| June 30, 2019 | 14.59M |
| March 31, 2019 | 11.09M |
| December 31, 2018 | 3.564M |
| September 30, 2018 | 1.436M |
| June 30, 2018 | -1.823M |
| March 31, 2018 | -1.665M |
| December 31, 2017 | -2.062M |
| September 30, 2017 | -1.754M |
| June 30, 2017 | -1.636M |
| March 31, 2017 | -2.207M |
| December 31, 2016 | -1.820M |
| September 30, 2016 | -1.720M |
| June 30, 2016 | -1.193M |
| March 31, 2016 | -0.906M |
| December 31, 2015 | -1.088M |
| September 30, 2015 | -0.7103M |
| June 30, 2015 | -0.5028M |
| March 31, 2015 | -0.3883M |
| December 31, 2014 | -0.2786M |
| September 30, 2014 | -0.0383M |
| June 30, 2014 | -0.001M |
| March 31, 2014 | 0.0008M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | 4.738M |
| InMed Pharmaceuticals, Inc. | 6.892M |
| NervGen Pharma Corp. | 12.18M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Clearmind Medicine, Inc. | 11.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.678M |
| Total Liabilities (Quarterly) | 14.33M |
| Debt to Equity Ratio | -1.291 |
| Current Ratio | 0.1743 |
| Net Debt Paydown Yield | -7.57% |